YS

Yanni Souroutzidis

#370 out of 1697 analysts
Cantor Fitzgerald
Automatically Tracked
Tracking: 0 Updated: Aug 20 at 01:23 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
25.94%
Gain
Monthly
3.64%
Yearly
25.94%
Drawdown
48.37%
$125,944.17
Equity
Holdings
$125,944.17
Cash
$0
Investment
$125,944.17
$25,944.17
Profit
Realized
$25,944.17
Unrealized
$0
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$0
Win %
100%
This Week
Compared To Last Week
Gain
25.94%
Profit
$25,944.17
Win %
100%
This Month
Compared to last month
Gain
25.94%
Profit
$25,944.17
Win %
100%
This Year
Compared to last year
Gain
25.94%
Profit
$25,944.17
Win %
100%
Agomab Therapeutics NV logo
AGMB Agomab Therapeutics NV
+0.15%
+$183.19
No Data
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
2
Longs Won
1/2 50%
Profit Factor
-
Profitability
Shorts Won
0/0 0%
Standard Deviation
$0
Average Win
$25,944.17
Best Trade
(May 16) $25,944.17
Sharpe Ratio
0
Average Loss
$0
Worst Trade
-
Z-Score
0 (0%)
Commissions
$0
Avg. Trade Length
1m 2w 6d
Expectancy
$12,972.09
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01%
Consecutive Losing Trades
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
Agomab Therapeutics NV logo
AGMB Agomab Therapeutics NV
9,159.58 $125,944.17 $125,944.17 - - -
+0.146%
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV